- Escalation vs. induction therapy in multiple sclerosis2017 | Faculty of Medicine in Pilsen
- Ocrelizumab since the first multiple sclerosis attack - a milestone in reimbursement criteria2022 | First Faculty of Medicine
- Multiple sclerosis: treatment, monitoring, activity and disability2018 | Faculty of Medicine in Hradec Králové
- Parameter NEDA-3 from the point of view of current treatment of multiple sclerosis2023 | Faculty of Medicine in Hradec Králové
- Evaluation of multiple sclerosis treatment efficacy in 21st century2019 | First Faculty of Medicine
- Long-term therapy of multiple sclerosis with fingolimod - results of 4.5-year extension study to TRANSFORMS2016 | Publication without faculty affiliation